Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | IDH1 | O75874 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10960748 | 0.92 | TDP1 (0.40) | ALDH1A1L3MBTL1TDP1USP2HPGD | |
| SCHEMBL4749847 | 0.87 | CYP3A4 (0.36) | ALDH1A1TDP1CYP3A4IDH1TSHR | |
| SCHEMBL14233383 | 0.79 | MAOB (0.37) | ALDH1A1TDP1USP2HPGD | |
| SCHEMBL29179 | 0.79 | CYP3A4 (0.45) | ALDH1A1TDP1CYP3A4 | |
| SCHEMBL35092 | 0.79 | CYP3A4 (0.45) | ALDH1A1TDP1CYP3A4 | |
| SCHEMBL3680017 | 0.79 | CYP3A4 (0.33) | TDP1CYP3A4 | |
| SCHEMBL6054756 | 0.79 | CYP3A4 (0.33) | TDP1CYP3A4 | |
| SCHEMBL11550852 | 0.79 | HIF1A (0.36) | ALDH1A1TDP1CYP3A4TSHR | |
| Allylamine SCHEMBL11350886 | 0.79 | MAOA (0.35) | ALDH1A1TDP1CYP3A4 | |
| SCHEMBL4255002 | 0.77 | CYP3A4 (0.43) | TDP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022212124-A1 | PHOSPHONIUM-BORANE CATALYST COMPLEXES AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022212124-A1 | PHOSPHONIUM-BORANE CATALYST COMPLEXES AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-10-06 | — | — | WO | disclosed |
| EP-1735352-B1 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | CALIFORNIA INST OF TECHN (US) | 2019-08-21 | — | — | EP | disclosed |
| US-9238709-B2 | Latent, high-activity olefin metathesis catalysts containing an N-heterocyclic carbene ligand | MATERIA, INC. (US) | 2016-01-19 | — | — | US | disclosed |
| US-20150141603-A1 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-05-21 | — | — | US | disclosed |
| US-8871879-B2 | Latent, high-activity olefin metathesis catalysts containing an N-heterocyclic carbene ligand | MATERIA, INC. (US) | 2014-10-28 | — | — | US | disclosed |
| US-20130296511-A1 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-11-07 | — | — | US | disclosed |
| US-20130064843-A1 | Identification of conserved peptide blocks in homologous polypeptides | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2013-03-14 | — | — | US | disclosed |
| CN-101090915-A | Latent, high-activity olefin metathesis catalysts containing an n-heterocyclic carbene ligand | CALIFORNIA INST OF TECHN (US) | 2007-12-19 | — | — | CN | disclosed |
| EP-1735352-A2 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2006-12-27 | — | — | EP | disclosed |
| US-20050261451-A1 | Latent, high-activity olefin metathesis catalysts containing an N-heterocyclic carbene ligand | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-11-24 | — | — | US | disclosed |
| WO-2005094345-A2 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-10-13 | — | — | WO | disclosed |
| EP-0623149-A4 | POLYMERIZATION OF FUNCTIONALIZED MONOMERS WITH ZIEGLER-NATTA CATALYSTS. | UNIV LELAND STANFORD JUNIOR (US) | 1995-09-27 | — | — | EP | disclosed |
| EP-0623149-A4 | POLYMERIZATION OF FUNCTIONALIZED MONOMERS WITH ZIEGLER-NATTA CATALYSTS. | UNIV LELAND STANFORD JUNIOR (US) | 1995-09-27 | — | — | EP | disclosed |
| EP-0623149-A1 | POLYMERIZATION OF FUNCTIONALIZED MONOMERS WITH ZIEGLER-NATTA CATALYSTS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 1994-11-09 | — | — | EP | disclosed |
| EP-0623149-A1 | POLYMERIZATION OF FUNCTIONALIZED MONOMERS WITH ZIEGLER-NATTA CATALYSTS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 1994-11-09 | — | — | EP | disclosed |
| WO-1994012547-A3 | POLYMERIZATION OF FUNCTIONALIZED MONOMERS WITH ZIEGLER-NATTA CATALYSTS | UNIV LELAND STANFORD JUNIOR (US) | 1994-07-21 | — | — | WO | disclosed |
| WO-1994012547-A2 | POLYMERIZATION OF FUNCTIONALIZED MONOMERS WITH ZIEGLER-NATTA CATALYSTS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 1994-06-09 | — | — | WO | disclosed |
| WO-1994012547-A2 | POLYMERIZATION OF FUNCTIONALIZED MONOMERS WITH ZIEGLER-NATTA CATALYSTS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 1994-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261451-A1 | Latent, high-activity olefin metathesis catalysts containing an N-heterocyclic carbene ligand | CDK8, LTC4S, ZCCHC8 | ALDH1A1 1944/4885L3MBTL1 782/4885TDP1 3370/4885 |
| US-20130296511-A1 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | CDK8, LTC4S, ZCCHC8 | ALDH1A1 1944/4885L3MBTL1 782/4885TDP1 3370/4885 |
| US-20150141603-A1 | LATENT, HIGH-ACTIVITY OLEFIN METATHESIS CATALYSTS CONTAINING AN N-HETEROCYCLIC CARBENE LIGAND | CDK8, LTC4S, ZCCHC8 | ALDH1A1 1944/4885L3MBTL1 782/4885TDP1 3370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.